MANAGED CARE ORGANIZATIONS AND DRUG TREATMENT

管理式医疗组织和药物治疗

• 批准号: 2733595
• 负责人: THOMAS A D'AUNNO
• 金额: $ 39.86万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-07-25 至 1999-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2733595
• 关键词: behavioral /social science research tag; drug abuse therapy; health care cost /financing; health care facility; health care model; health care policy; health care quality; health care service availability; health care service evaluation; health care service organization; health insurance; health services research tag; hospital length of stay; human subject; interview; managed care; outcomes research; patient care management

DESCRIPTION: (Applicant's Abstract) Behavioral Health Managed Care Organizations (BHMCOs) play a key role in managed care in drug abuse services. These units have the responsibility, and authority, to monitor and authorize payment for the provision of care. However, little is known about these units. The current proposal aims to: 1) describe the range and organization of a random sample of BHMCOs; 2) describe the variation in rules and procedures, or "managed care mechanisms," BHMCOs impose on providers; 3) determine the impact of the managed care mechanisms on the services of a random sample of providers; 4) determine the impact of BHMCO internal and environmental characteristics on the managed care mechanisms; and S) to therefore determine the impact of BHMCO internal and environmental characteristics on the services delivered by drug abuse providers. This study builds on The Drug Abuse Treatment System survey, a rigorous longitudinal random sample of outpatient drug abuse treatment providers. It will use the survey to obtain random samples of providers who have managed care contracts (n=180) and BHMCOs that administer each such contract (n-4~). It will build upon previous analyses to develop reliable measures of such factors as: managed care mechanisms, including financial risk mechanisms, bureaucratic mechanisms, and treatment content mechanisms; BHMCO internal and environmental characteristics, such as auspices, age, the degree of competition, and external regulations. The research will measure provider behaviors that affect outcomes: treatment duration, rates of service provision, and access to further care. It will measure costs and benefits of managed care administration. Beyond providing unprecedented descriptions of BHMCO and managed care arrangements in general, the statistical analyses will use multivariate regressions, random regression models, and sample selection models to: 1) predict the nature of managed care mechanisms by BHMCO internal and environmental arrangements; and 2) determine the impact of BHMCO arrangements on provider outcomes, benefits, and costs.

描述：(申请人摘要) 行为健康管理保健组织(BHMCO)在以下方面发挥关键作用 药物滥用服务中的管理性护理。这些单位有责任， 和权力，以监督和授权提供护理的付款。 然而，人们对这些单位知之甚少。目前的建议旨在： 1)描述BHMCO随机样本的范围和组织；2) 描述规则和程序的变化，或“管理型护理” 机制，“BHMCO强加于提供者；3)确定 关于随机抽样提供者服务的管理式保健机制；4) 确定BHMCO的内部和环境特征对 管理下的保健机制；和S)因此确定 BHMCO提供的服务的内部和环境特征 由药物滥用提供者提供。 这项研究建立在药物滥用治疗系统调查的基础上，这是一项严格的 门诊药物滥用治疗提供者纵向随机抽样。它 将使用调查来获得随机抽样的提供者，这些提供者 护理合同(n=180)和管理每个此类合同的BHMCO(n-4~)。 它将建立在以前的分析基础上，以制定可靠的衡量标准 因素包括：管理性保健机制，包括财务风险机制， 官僚机制和治疗内容机制；BHMCO内部 和环境特征，如主持程度、年龄、 竞争和外部法规。这项研究将衡量供应商 影响结果的行为：治疗持续时间、服务率 提供和获得进一步护理的机会。它将衡量成本和收益 管理型医疗管理。除了提供前所未有的描述 关于BHMCO和管理性护理安排的总体情况，统计分析 将使用多元回归、随机回归模型和样本 选择模型以：1)通过以下方式预测管理型医疗保健机制的性质 BHMCO内部和环境安排；以及2)确定影响 关于供应商结果、收益和成本的BHMCO安排。